Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV.
D000328:Adult; D001647:Bile Acids and Salts / Q000378:metabolism*; D002635:Chenodeoxycholic Acid / Q000378:metabolism; D004083:Cholestanol / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D002793:Cholic Acids / Q000378:metabolism; D005243:Feces / Q000378:metabolism; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000378:metabolism*; D006949:Hyperlipidemias / Q000188:drug therapy / Q000378:metabolism*; D007700:Kinetics; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013256:Steroids / Q000378:metabolism*; D014280:Triglycerides / Q000097:blood; D014973:Xanthomatosis / Q000378:metabolism
D001647:Bile Acids and Salts; D002793:Cholic Acids; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D009539:Nicotinic Acids; D013256:Steroids; D014280:Triglycerides; D002635:Chenodeoxycholic Acid; D004083:Cholestanol; D002784:Cholesterol